SCHEMBL3853221

SCHEMBL3853221

CCc1cccc(CC)c1-c1nc(C)c(S(=O)(=O)CN2CCOc3ccc(C)nc32)c(N2CCC(C(N)=O)CC2)n1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
TSHR P16473 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
MAPT P10636 3/20 0.33
ALOX12 P18054 2/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PKM P14618 1/20 0.32
PTGER3 P43115 1/20 0.32
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62683 0.87 TSHR (0.36) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL72658 0.79 TSHR (0.34) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL62209 0.75 GBA1 (0.31) KDM4ENPSR1PKM
SCHEMBL3837047 0.74 PTGER3 (0.33) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL62176 0.74 PTGER3 (0.31) ALDH1A1TSHRMAPTLMNANPSR1
SCHEMBL3509664 0.73 PTGER3 (0.32) PTGER3
SCHEMBL62172 0.71 MEN1 (0.34) KDM4ETSHRCYP2C19LMNAMEN1
SCHEMBL61695 0.71 PTGER3 (0.32) PKMPTGER3
SCHEMBL62739 0.70 GBA1 (0.37)
SCHEMBL61175 0.70 CYP11B2 (0.41) SMN1; SMN2KDM4EALDH1A1TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745033-A4 4,5-DISUBSTITUTED-2-ARYL PYRIMIDINES NEUROGEN CORP (US) 2009-08-26 EP claimed
EP-1745033-A2 4,5-DISUBSTITUTED-2-ARYL PYRIMIDINES NEUROGEN CORPORATION (US) 2007-01-24 EP claimed
WO-2005110416-A2 4,5-DISUBSTITUTED-2-ARYL PYRIMIDINES NEUROGEN CORPORATION (US) 2005-11-24 WO claimed